Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2

Wang, Qihui, Zhang, Yanfang, Wu, Lili, Niu, Sheng, Song, Chunli, Zhang, Zengyuan, Lu, Guangwen, Qiao, Chengpeng +6 more·2020·Cell
DOI 10.1016/j.cell.2020.03.045

Cited by (1,009)

Items 301–400 of 1,009

  1. A focused review on technologies, mechanisms, safety, and efficacy of available COVID-19 vaccines
    Parisa Ghasemiyeh, Soliman Mohammadi‐Samani, Negar Firouzabadi, Ali Dehshahri, Afsaneh Vazin · 2021 · International Immunopharmacology
  2. SARS-CoV-2 and the Host Cell: A Tale of Interactions
    Massimo Pizzato, Chiara Baraldi, Giulia Boscato Sopetto, Davide Finozzi, Carmelo Gentile, Michele Domenico Gentile, Roberta Marconi, Dalila Paladino, Alberto Raoss, Ilary Riedmiller et al. · 2022 · Frontiers in Virology
  3. Molecular basis of the potential interaction of SARS-CoV-2 spike protein to CD147 in COVID-19 associated-lymphopenia
    Mohamed A. Helal, Shaimaa Shouman, Ahmad Abdelwaly, Ahmed Osama Elmehrath, Mohamed Essawy, Shireen M. Sayed, Amr Hany Saleh, Nagwa El‐Badri · 2020 · Journal of Biomolecular Structure and Dynamics
  4. Nucleic Acid-Based Diagnostic Tests for the Detection SARS-CoV-2: An Update
    Choo Yee Yu, Kok‐Gan Chan, Chan Yean Yean, Geik Yong Ang · 2021 · Diagnostics
  5. Conformational dynamics and allosteric modulation of the SARS-CoV-2 spike
    Marco Aurelio Díaz-Salinas, Qi Li, Monir Ejemel, Leonid Yurkovetskiy, Jeremy Luban, Kuang Shen, Yang Wang, James B. Munro · 2022 · eLife
  6. Cardiac inflammation in COVID-19: Lessons from heart failure
    Sathya Dev Unudurthi, Priya Luthra, Rajendran JC Bose, Jason R. McCarthy, Maria Irene Kontaridis · 2020 · Life Sciences
  7. A tandem-repeat dimeric RBD protein-based covid-19 vaccine zf2001 protects mice and nonhuman primates
    Yaling An, Shihua Li, Xiyue Jin, Jian-Bao Han, Kun Xu, Senyu Xu, Yuxuan Han, Chuanyu Liu, Tianyi Zheng, Mei Liu et al. · 2022 · Emerging Microbes & Infections
  8. Functional importance of the D614G mutation in the SARS-CoV-2 spike protein
    Cody B. Jackson, Lizhou Zhang, Michael Farzan, Hyeryun Choe · 2020 · Biochemical and Biophysical Research Communications
  9. The natural way forward: Molecular dynamics simulation analysis of phytochemicals from Indian medicinal plants as potential inhibitors of SARS‐CoV ‐2 targets
    Pratap Kumar Parida, Dipak Paul, Debamitra Chakravorty · 2020 · Phytotherapy Research
  10. Cross-species recognition of SARS-CoV-2 to bat ACE2
    Kefang Liu, Shuguang Tan, Sheng Niu, Jia Wang, Lili Wu, Huan Sun, Yanfang Zhang, Xiaoqian Pan, Xiao Qu, Pei Du et al. · 2020 · Proceedings of the National Academy of Sciences
  11. SARS-CoV-2 mutations acquired in mink reduce antibody-mediated neutralization
    Markus Hoffmann, Lu Zhang, Nadine Krüger, Luise Graichen, Hannah Kleine‐Weber, Heike Hofmann-Winkler, Amy Madeleine Kempf, Stefan Nessler, Joachim Riggert, Martin Sebastian Winkler et al. · 2021 · Cell Reports
  12. De Novo Discovery of High-Affinity Peptide Binders for the SARS-CoV‑2 Spike Protein
    Sebastian J. Pomplun, Muhammad Jbara, Anthony J. Quartararo, Genwei Zhang, Joseph S. Brown, Yen‐Chun Lee, Xiyun Ye, Stephanie Hanna, Bradley L. Pentelute · 2020 · ACS Central Science
  13. In Silico Investigation of the New UK (B.1.1.7) and South African (501Y.V2) SARS-CoV-2 Variants with a Focus at the ACE2–Spike RBD Interface
    Bruno O. Villoutreix, Vincent Cálvez, Anne‐Geneviève Marcelin, Abdel‐Majid Khatib · 2021 · International Journal of Molecular Sciences
  14. Targetable elements in SARS-CoV-2 S2 subunit for the design of pan-coronavirus fusion inhibitors and vaccines
    Liyan Guo, Sheng Lin, Zimin Chen, Yu Cao, Bin He, Guangwen Lu · 2023 · Signal Transduction and Targeted Therapy
  15. Challenges and opportunities for antiviral monoclonal antibodies as COVID-19 therapy
    Carlos A Cruz-Teran, Karthik Tiruthani, Morgan D. McSweeney, Alice D. Ma, R. Pickles, S. Lai · 2020 · Advanced Drug Delivery Reviews
  16. Seroprevalence of SARS-CoV-2 (COVID-19) exposure in pet cats and dogs in Minnesota, USA
    Mythili Dileepan, Da Di, Qinfeng Huang, Shamim Ahmed, Daniel A. Heinrich, Hinh Ly, Yuying Liang · 2021 · Virulence
  17. Differential Interactions between Human ACE2 and Spike RBD of SARS-CoV-2 Variants of Concern
    Seonghan Kim, Yi Liu, Zewei Lei, Jeffrey Dicker, Yiwei Cao, X. Frank Zhang, Wonpil Im · 2021 · Journal of Chemical Theory and Computation
  18. COVID‐19 diagnostic testing: Technology perspective
    Meng Xu, Dan Wang, Hongye Wang, Xiaomei Zhang, Te Liang, Jiayu Dai, Meng Li, Jiahui Zhang, Kai Zhang, Danke Xu et al. · 2020 · Clinical and Translational Medicine
  19. Metabolic associated fatty liver disease increases the severity of COVID-19: A meta-analysis
    Lu Pan, Pan Huang, Xia Xie, Jiachen Xu, Dawei Guo, Yuan Jiang · 2020 · Digestive and Liver Disease
  20. COVID-19 mRNA vaccines
    Qingrui Huang, Jiawei Zeng, Jinghua Yan · 2021 · Journal of genetics and genomics/Journal of Genetics and Genomics
  21. A potential role for Galectin-3 inhibitors in the treatment of COVID-19
    John L. Caniglia, Maheedhara Reddy Guda, Swapna Asuthkar, Andrew J. Tsung, Kiran Kumar Velpula · 2020 · PeerJ
  22. ACE2 and ACE: structure-based insights into mechanism, regulation and receptor recognition by SARS-CoV
    Lizelle Lubbe, Gyles E. Cozier, Delia Oosthuizen, K. Ravi Acharya, Edward D. Sturrock · 2020 · Clinical Science
  23. Recent advances in SARS-CoV-2 Spike protein and RBD mutations comparison between new variants Alpha (B.1.1.7, United Kingdom), Beta (B.1.351, South Africa), Gamma (P.1, Brazil) and Delta (B.1.617.2, India)
    Paulo Ricardo da Silva Sanches, Ives Charlie‐Silva, Helyson Lucas Bezerra Braz, Cíntia Bittar, Marília Freitas Calmon, Paula Rahal, Eduardo Maffud Cilli · 2021 · Journal of Virus Eradication
  24. SARS-CoV-2 Variants Increase Kinetic Stability of Open Spike Conformations as an Evolutionary Strategy
    Ziwei Yang, Yang Han, Shilei Ding, Wei Shi, Tongqing Zhou, Andrés Finzi, Peter D. Kwong, Walther Mothes, Maolin Lu · 2022 · mBio
  25. The Pathophysiology of Long COVID throughout the Renin-Angiotensin System
    Shaymaa Khazaal, Julien Harb, Mohamad Rima, Cédric Annweiler, Yingliang Wu, Zhijian Cao, Ziad Abi Khattar, Christian Legros, Hervé Kovacic, Ziad Fajloun et al. · 2022 · Molecules
  26. Structural and biochemical mechanism for increased infectivity and immune evasion of Omicron BA.2 variant compared to BA.1 and their possible mouse origins
    Youwei Xu, Canrong Wu, Xiaodan Cao, Chunyin Gu, Heng Liu, Mengting Jiang, Xiaoxi Wang, Qingning Yuan, Kaichun Wu, Jia Liu et al. · 2022 · Cell Research
  27. Bench-to-bedside: Innovation of small molecule anti-SARS-CoV-2 drugs in China
    Liyan Yang, Zhonglei Wang · 2023 · European Journal of Medicinal Chemistry
  28. Comparative Genomic Analysis of Rapidly Evolving SARS-CoV-2 Reveals Mosaic Pattern of Phylogeographical Distribution
    Roshan Kumar, Helianthous Verma, Nirjara Singhvi, Utkarsh Sood, Vipin Gupta, Mona Singh, RASHMI REKHA KUMARI, Princy Hira, Shekhar Nagar, Chandni Talwar et al. · 2020 · mSystems
  29. SARS-CoV-2-specific ELISA development
    Vicky Roy, Stephanie Fischinger, Caroline G. Atyeo, Matthew D. Slein, Carolin Loos, Alejandro Benjamin Balazs, Corinne Luedemann, Michael Gerino Astudillo, Diane Yang, Duane R. Wesemann et al. · 2020 · Journal of Immunological Methods
  30. Structural Basis of SARS-CoV-2 and SARS-CoV Antibody Interactions
    Edem Gavor, Yeu Khai Choong, Shi Yin Er, Hariharan Sivaraman, Jayaraman Sivaraman · 2020 · Trends in Immunology
  31. The COVID-19 Vaccines: Recent Development, Challenges and Prospects
    Yuxin Yan, Yoong Xin Pang, Zhuoyi Lyu, Ruiqi Wang, Xinyun Wu, Chong You, Haitao Zhao, Sivakumar Manickam, Edward Henry Lester, Tao Wu et al. · 2021 · Vaccines
  32. Inhibition of acid sphingomyelinase by ambroxol prevents SARS-CoV-2 entry into epithelial cells
    Alexander Carpinteiro, Barbara Gripp, Markus Hoffmann, Stefan Pöhlmann, Nicolas Hoertel, Michael J. Edwards, Markus Kamler, Johannes Kornhuber, Katrin Anne Becker, Erich Gulbins · 2021 · Journal of Biological Chemistry
  33. Overcoming Culture Restriction for SARS-CoV-2 in Human Cells Facilitates the Screening of Compounds Inhibiting Viral Replication
    Santseharay Ramírez, Carlota Fernandez-Antunez, Andrea Galli, Alexander P. Underwood, Long V. Pham, Line Abildgaard Ryberg, Shan Feng, Martin Schou Pedersen, Lotte S. Mikkelsen, Sandrine Belouzard et al. · 2021 · Antimicrobial Agents and Chemotherapy
  34. In vitro data suggest that Indian delta variant B.1.617 of SARS‐CoV‐2 escapes neutralization by both receptor affinity and immune evasion
    Gilles Sousa Augusto, Mona Omar Mohsen, Simon Zinkhan, Xuelan Liu, Monique Vogel, Martin F. Bachmann · 2021 · Allergy
  35. Conformational dynamics of the Beta and Kappa SARS-CoV-2 spike proteins and their complexes with ACE2 receptor revealed by cryo-EM
    Yifan Wang, Cong Xu, Yanxing Wang, Hong Qin, Chao Zhang, Zuyang Li, Shiqi Xu, Qinyu Zuo, Caixuan Liu, Zhong Wei Huang et al. · 2021 · Nature Communications
  36. Investigation of the Effect of Temperature on the Structure of SARS-CoV-2 Spike Protein by Molecular Dynamics Simulations
    Soumya Lipsa Rath, Kishant Kumar · 2020 · Frontiers in Molecular Biosciences
  37. Mutations in the SARS-CoV-2 spike RBD are responsible for stronger ACE2 binding and poor anti-SARS-CoV mAbs cross-neutralization
    Masaud Shah, Bilal Ahmad, Sangdun Choi, Hyun Goo Woo · 2020 · Computational and Structural Biotechnology Journal
  38. Priming of SARS-CoV-2 S protein by several membrane-bound serine proteinases could explain enhanced viral infectivity and systemic COVID-19 infection
    Pablo Fuentes‐Prior · 2020 · Journal of Biological Chemistry
  39. Stereotypic neutralizing VH antibodies against SARS-CoV-2 spike protein receptor binding domain in patients with COVID-19 and healthy individuals
    Sang Il Kim, Jinsung Noh, Sujeong Kim, Younggeun Choi, Duck Kyun Yoo, Yonghee Lee, Hyunho Lee, Jongtak Jung, C. K. Kang, K. Song et al. · 2021 · Science Translational Medicine
  40. Anticoagulation in COVID-19: current concepts and controversies
    Atanu Chandra, Uddalak Chakraborty, Shrestha Ghosh, Sugata Dasgupta · 2021 · Postgraduate Medical Journal
  41. An AAV-based, room-temperature-stable, single-dose COVID-19 vaccine provides durable immunogenicity and protection in non-human primates
    Nerea Zabaleta, Wenlong Dai, Urja Bhatt, Cécile Hérate, Pauline Maisonnasse, Jessica A. Chichester, Julio C. Sanmiguel, Reynette Estelien, Kristofer T. Michalson, Cheikh Diop et al. · 2021 · Cell Host & Microbe
  42. A bispecific monomeric nanobody induces spike trimer dimers and neutralizes SARS-CoV-2 in vivo
    L. Hanke, H. Das, D. Sheward, Laura Perez Vidakovics, E. Urgard, Ainhoa Moliner-Morro, Changil Kim, V. Karl, A. Pankow, Natalie L. Smith et al. · 2022 · Nature Communications
  43. SARS-CoV-2 Infections and ACE2: Clinical Outcomes Linked With Increased Morbidity and Mortality in Individuals With Diabetes
    Alexander G. Obukhov, Bruce R. Stevens, Ram Prasad, Sergio Li Calzi, Michael E. Boulton, Mohan K. Raizada, Gavin Y. Oudit, Maria B. Grant · 2020 · Diabetes
  44. Vaccine formulations in clinical development for the prevention of severe acute respiratory syndrome coronavirus 2 infection
    Cole J. Batty, Mark T. Heise, Eric M. Bachelder, Kristy M. Ainslie · 2020 · Advanced Drug Delivery Reviews
  45. Unraveling the mechanism of arbidol binding and inhibition of SARS-CoV-2: Insights from atomistic simulations
    Aditya Kumar Padhi, Aniruddha Seal, Javed Masood Khan, Maqusood Ahamed, Timir Tripathi · 2020 · European Journal of Pharmacology
  46. Synthetic Homogeneous Glycoforms of the SARS‐CoV‐2 Spike Receptor‐Binding Domain Reveals Different Binding Profiles of Monoclonal Antibodies
    Farong Ye, Jie Zhao, Peng Hui Xu, Xinliang Liu, Jing Quan Yu, Wei Shangguan, Jiazhi Liu, Xiaosheng Luo, Cheng Li, Tianlei Ying et al. · 2021 · Angewandte Chemie International Edition
  47. Viral proteins recognized by different TLRs
    Rui Zhou, Li Liu, Yu Wang · 2021 · Journal of Medical Virology
  48. Broadly-Neutralizing Antibodies Against Emerging SARS-CoV-2 Variants
    Lok Bahadur Shrestha, Nicodemus T. Tedla, Rowena Anne Bull · 2021 · Frontiers in Immunology
  49. The mechanisms of action of ivermectin against SARS-CoV-2—an extensive review
    Asiya Kamber Zaidi, Puya Dehgani‐Mobaraki · 2021 · The Journal of Antibiotics
  50. The Modulation of Mucosal Antiviral Immunity by Immunobiotics: Could They Offer Any Benefit in the SARS-CoV-2 Pandemic?
    Julio Villena, Haruki Kitazawa · 2020 · Frontiers in Physiology
  51. Natural compounds fromClerodendrumspp. as possible therapeutic candidates against SARS-CoV-2: Anin silicoinvestigation
    Pallab Kar, Neeta Raj Sharma, Bhupender Singh, Arnab Sen, Ayan Roy · 2020 · Journal of Biomolecular Structure and Dynamics
  52. The Global Emergency of Novel Coronavirus (SARS-CoV-2): An Update of the Current Status and Forecasting
    Hossein Hozhabri, Francesca Piceci‐Sparascio, Hamidreza Sohrabi, Leila Mousavifar, René Roy, Daniela Scribano, Alessandro De Luca, Cecilia Ambrosi, Meysam Sarshar · 2020 · International Journal of Environmental Research and Public Health
  53. Repurposing anticancer drugs for the management of COVID-19
    Khalid El Bairi, Dario Trapani, Angelica Petrillo, Cécile Le Page, Hanaâ Zbakh, Bruno Daniele, Rhizlane Belbaraka, Giuseppe Curigliano, Saïd Afqir · 2020 · European Journal of Cancer
  54. Topography, Spike Dynamics, and Nanomechanics of Individual Native SARS-CoV-2 Virions
    Bálint Kiss, Zoltán Kis, Bernadett Pályi, Miklós Kellermayer · 2021 · Nano Letters
  55. Marine sulfated polysaccharides as potential antiviral drug candidates to treat Corona Virus disease (COVID-19)
    Monic Andrew, G. Jayaraman · 2021 · Carbohydrate Research
  56. Computational prediction of the effect of amino acid changes on the binding affinity between SARS-CoV-2 spike RBD and human ACE2
    Chen Chen, Veda Sheersh Boorla, Deepro Banerjee, Ratul Chowdhury, Victoria S. Cavener, Ruth Helmus Nissly, Abhinay Gontu, Nina R. Boyle, Kurt J. Vandegrift, Meera Surendran Nair et al. · 2021 · Proceedings of the National Academy of Sciences
  57. Therapeutic stapled peptides: Efficacy and molecular targets
    Yulei Li, Minghao Wu, Yinxue Fu, Jingwen Xue, Fei Yuan, Tianci Qu, Anastassia N. Rissanou, Yilin Wang, Xiang Li, Honggang Hu · 2024 · Pharmacological Research
  58. Current laboratory diagnostics of coronavirus disease 2019 (COVID-19).
    Giuseppe Lippi, Camilla Mattiuzzi, Chiara Bovo, Mario Plebani · 2020 · Acta bio-medica dell'Ateneo parmense/Acta biomedica
  59. Current Status of Laboratory Diagnosis for COVID-19: A Narrative Review
    Antonio Russo, Carmine Minichini, Mario Starace, Roberta Astorri, Federica Calò, Nicola Coppola · 2020 · Infection and Drug Resistance
  60. Covid-19 and blood groups: ABO antibody levels may also matter
    Marie Deleers, Adrien Breiman, Valéry Daubie, Carine Maggetto, Isabelle Barreau, Tatiana Besse, Béatrice Clemenceau, Nathalie Ruvoën‐Clouet, Jean‐François Fils, Evelyne Maillart et al. · 2020 · International Journal of Infectious Diseases
  61. Two-step fitness selection for intra-host variations in SARS-CoV-2
    Jiarui Li, Pengcheng Du, Lijiang Yang, Ju Zhang, Chuan Song, Danying Chen, Yangzi Song, Nan Ding, Mingxi Hua, Kai Han et al. · 2021 · Cell Reports
  62. Computational Alanine Scanning and Structural Analysis of the SARS-CoV-2 Spike Protein/Angiotensin-Converting Enzyme 2 Complex
    Erik Laurini, Domenico Marson, Suzana Aulić, Maurizio Fermeglia, Sabrina Pricl · 2020 · ACS Nano
  63. Generation of SARS-CoV-2 Spike Pseudotyped Virus for Viral Entry and Neutralization Assays: A 1-Week Protocol
    José Manuel Cóndor Capcha, Guerline Lambert, Derek Michael Dykxhoorn, Alessandro Gonzalez Salerno, Joshua M. Hare, Michael A. Whitt, Savita G. Pahwa, Dushyantha T. Jayaweera, Lina A. Shehadeh · 2021 · Frontiers in Cardiovascular Medicine
  64. SARS-CoV-2 Infection: New Molecular, Phylogenetic, and Pathogenetic Insights. Efficacy of Current Vaccines and the Potential Risk of Variants
    John Charles Rotondo, Fernanda Martini, Martina Maritati, Chiara Mazziotta, Giulia Di Mauro, Carmen Lanzillotti, Nicole Barp, Altea Gallerani, Mauro G. Tognon, Carlo Contini · 2021 · Viruses
  65. Metallodrug Profiling against SARS‐CoV‐2 Target Proteins Identifies Highly Potent Inhibitors of the S/ACE2 interaction and the Papain‐like Protease PL pro
    María Gil‐Moles, Sebastian Türck, Uttara Basu, Andrea Pettenuzzo, Saurav Bhattacharya, Ananthu Rajan, Xiang Ma, Rolf Büssing, Jessica Wölker, Hilke Burmeister et al. · 2021 · Chemistry - A European Journal
  66. Impact of COVID‐19 and other viruses on reproductive health
    Osamah Batiha, Taghleb Al‐Deeb, Esra’a Al‐zoubi, Emad Alsharu · 2020 · Andrologia
  67. Analysis of ACE2 genetic variants in 131 Italian SARS-CoV-2-positive patients
    Antonio Novelli, Michela Biancolella, Paola Borgiani, Dario Cocciadiferro, Vito Luigi Colona, Maria Rosaria D’Apice, Paola Rogliani, Salvatore Zaffina, Francesca Leonardis, Andrea Campana et al. · 2020 · Human Genomics
  68. Potent Neutralization of SARS-CoV-2 by Hetero-Bivalent Alpaca Nanobodies Targeting the Spike Receptor-Binding Domain
    Huan Ma, Weihong Zeng, Xiang-Zhi Meng, Xiaoxue Huang, Yunru Yang, Dan Zhao, Peigen Zhou, Xiao-Fang Wang, Chang-Cheng Zhao, Yong-Jun Sun et al. · 2021 · Journal of Virology
  69. A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2
    Qingrui Huang, Kai Ji, Siyu Tian, Fengze Wang, Baoying Huang, Zhou Tong, Shuguang Tan, Junfeng Hao, Qihui Wang, Wenjie Tan et al. · 2021 · Nature Communications
  70. A Centenary Tale of Two Pandemics: The 1918 Influenza Pandemic and COVID-19, Part I
    David Michael Morens, Jeffery K. Taubenberger, Anthony S. Fauci · 2021 · American Journal of Public Health
  71. Discovery of Cyclic Peptide Ligands to the SARS-CoV-2 Spike Protein Using mRNA Display
    Alexander R. Norman, Charlotte Franck, Mary Christie, Paige M. E. Hawkins, Karishma Patel, Anneliese S. Ashhurst, Anupriya Aggarwal, Jason K. K. Low, Rezwan Siddiquee, Caroline L. Ashley et al. · 2021 · ACS Central Science
  72. The Role of Neuropilin-1 (NRP-1) in SARS-CoV-2 Infection: Review
    Monika Gudowska-Sawczuk, Barbara Mroczko · 2021 · Journal of Clinical Medicine
  73. The SARS‐CoV‐2 pandemic is associated with increased severity of presentation of childhood onset type 1 diabetes mellitus: A multi‐centre study of the first COVID‐19 wave
    Sinead Mary McGlacken-Byrne, Samantha Drew, Kelly Turner, Catherine J. Peters, Rakesh Amin · 2021 · Diabetic Medicine
  74. The Importance of Vaccination in the Context of the COVID-19 Pandemic: A Brief Update Regarding the Use of Vaccines
    Bruna Aparecida Souza Machado, Katharine Valéria Saraiva Hodel, Larissa Moraes dos Santos Fonseca, Vinícius Couto Pires, Luis Alberto Breda Mascarenhas, Leone Peter Correia da Silva Andrade, Marcelo Albano Moret, Roberto José da Silva Badaró · 2022 · Vaccines
  75. SARS-CoV-2 infection in pediatric population before and during the Delta (B.1.617.2) and Omicron (B.1.1.529) variants era
    Haifa Khemiri, Kaouther Ayouni, Henda Triki, S Boubaker · 2022 · Virology Journal
  76. Immunopathology of galectin-3: an increasingly promising target in COVID-19
    John L. Caniglia, Swapna Asuthkar, Andrew J. Tsung, Maheedhara Reddy Guda, Kiran Kumar Velpula · 2020 · F1000Research
  77. Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies
    Renhong Yan, Ruoke Wang, Bin Ju, Jinfang Yu, Yuanyuan Zhang, Nan Liu, Jia Wang, Qi Zhang, Peng Chen, Bing Zhou et al. · 2021 · Cell Research
  78. Mutation Y453F in the spike protein of SARS-CoV-2 enhances interaction with the mink ACE2 receptor for host adaption
    Wenlin Ren, Jun Lan, Xiaohui Ju, Mingli Gong, Quanxin Long, Zihui Zhu, Yanying Yu, Jianping Wu, Jin Zhong, Rong Zhang et al. · 2021 · PLoS Pathogens
  79. Multidrug treatment with nelfinavir and cepharanthine against COVID-19
    Hirofumi Ohashi, Koichi Watashi, Wakana Saso, Kaho Shionoya, Shoya Iwanami, Takatsugu Hirokawa, Tsuyoshi Shirai, Shigehiko Kanaya, Yusuke Ito, Kwang Su Kim et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  80. Beyond Shielding: The Roles of Glycans in SARS-CoV-2 Spike Protein
    Lorenzo Casalino, Zied Gaieb, Jory A. Goldsmith, Christy K. Hjorth, Abigail C. Dommer, Aoife M. Harbison, Carl A. Fogarty, Emilia Pecora de Barros, Bryn C. Taylor, Jason S. McLellan et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  81. Potent Neutralizing Antibodies Directed to Multiple Epitopes on SARS-CoV-2 Spike
    Lihong Liu, Pengfei Wang, Manoj S. Nair, Jian Yu, Micah Rapp, Qian Wang, Yang Luo, Jasper F-W. Chan, Vincent Sahi, Amir Figueroa et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  82. Targeted therapy strategies against SARS‐CoV‐2 cell entry mechanisms: A systematic review of in vitro and in vivo studies
    Simin Seyedpour, Behzad Khodaei, Amir Hossein Loghman, Nasrin Seyedpour, Misagh Fathi Kisomi, Maryam Balibegloo, Sasan Salehi Nezamabadi, Bahareh Gholami, Amene Saghazadeh, Nima Rezaei · 2020 · Journal of Cellular Physiology
  83. Molecular Basis of SARS-CoV‑2 Infection and Rational Design of Potential Antiviral Agents: Modeling and Simulation Approaches
    Antonio Francés‐Monerris, Cécilia Hognon, Tom Miclot, Cristina García‐Iriepa, Isabel Iriepa, Alessio Terenzi, Stéphanie Grandemange, Giampaolo Barone, Marco Marazzi, Antonio Monari · 2020 · Journal of Proteome Research
  84. Breadth and function of antibody response to acute SARS-CoV-2 infection in humans
    Kuan-Ying A. Huang, T. Tan, Ting-Hua Chen, Chung-Guei Huang, R. Harvey, S. Hussain, Cheng-Pin Chen, Adam C. Harding, J. Gilbert-Jaramillo, Xu Liu et al. · 2021 · PLoS Pathogens
  85. Integrin mediates cell entry of the SARS-CoV-2 virus independent of cellular receptor ACE2
    Jianmin Liu, Fan Lü, Yinghua Chen, Edward F. Plow, Jun Qin · 2022 · Journal of Biological Chemistry
  86. MutateX: an automated pipeline for in silico saturation mutagenesis of protein structures and structural ensembles
    Matteo Tiberti, Thilde Terkelsen, Kristine Degn, Ludovica Beltrame, Tycho Canter Cremers, Isabelle da Piedade, Miriam Di Marco, Emiliano Maiani, Elena Papaleo · 2022 · Briefings in Bioinformatics
  87. SARS-CoV-2 uses CD4 to infect T helper lymphocytes
    Natália Silva Brunetti, Gustavo Gastão Davanzo, Diogo de Moraes, A. Ferrari, Gabriela Fabiano de Souza, Stéfanie Primon Muraro, Thiago L. Knittel, Vinicius de Oliveira Boldrini, Lauar de Brito Monteiro, João Victor Virgílio-da-Silva et al. · 2023 · eLife
  88. Induced dysregulation of ACE2 by SARS-CoV-2 plays a key role in COVID-19 severity
    Maryam Eskandari Mehrabadi, Roohullah Hemmati, Amin Tashakor, Ahmad Abolpour Homaei, Masoumeh Yousefzadeh, Karim Hemati, Saman Hosseinkhani · 2021 · Biomedicine & Pharmacotherapy
  89. SARS-CoV-2 Fusion Peptide has a Greater Membrane Perturbating Effect than SARS-CoV with Highly Specific Dependence on Ca2+
    Alex Liqi Lai, Jack H. Freed · 2021 · Journal of Molecular Biology
  90. A haemagglutination test for rapid detection of antibodies to SARS-CoV-2
    Alain Townsend, Pramila Rijal, Julie Huiyuan Xiao, Tiong Kit Tan, Kuan-Ying Arthur Huang, Lisa M. Schimanski, Jiandong Huo, Nimesh Gupta, Rolle Rahikainen, Philippa Clare Matthews et al. · 2021 · Nature Communications
  91. Distinct cytokine profiles associated with COVID-19 severity and mortality
    Karim Dorgham, Paul Quentric, Mehmet Gökkaya, Stéphane Marot, Christophe Parizot, Delphine Sauce, Amélie Guihot, Charles Edouard Luyt, Matthieu Schmidt, Julien Mayaux et al. · 2021 · Journal of Allergy and Clinical Immunology
  92. Comparative Perturbation-Based Modeling of the SARS-CoV-2 Spike Protein Binding with Host Receptor and Neutralizing Antibodies: Structurally Adaptable Allosteric Communication Hotspots Define Spike Sites Targeted by Global Circulating Mutations
    Gennady M. Verkhivker, Steve Agajanian, Deniz Yaşar Öztaş, Grace Gupta · 2021 · Biochemistry
  93. Structural Modeling of the SARS-CoV-2 Spike/Human ACE2 Complex Interface can Identify High-Affinity Variants Associated with Increased Transmissibility
    Hin Hark Gan, Alan Twaddle, Benoı̂t Marchand, Kristin C. Gunsalus · 2021 · Journal of Molecular Biology
  94. Coronaviruses and the central nervous system
    Susan Morgello · 2020 · Journal of NeuroVirology
  95. Ca2+-dependent mechanism of membrane insertion and destabilization by the SARS-CoV-2 fusion peptide
    George Khelashvili, Ambrose Plante, Milka Doktorova, Harel Weinstein · 2021 · Biophysical Journal
  96. Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain
    Gabriele Cerutti, Yicheng Guo, Pengfei Wang, Manoj S. Nair, Maple Wang, Yaoxing Huang, Jian Yu, Lihong Liu, Phinikoula S. Katsamba, Fabiana A. Bahna et al. · 2021 · Cell Reports
  97. Advanced Pulmonary and Cardiac Support of COVID-19 Patients: Emerging Recommendations From ASAIO—A “Living Working Document”
    Keshava Rajagopal, Steven P. Keller, Bindu H. Akkanti, Christian Bime, Pranav Loyalka, Faisal Habib Cheema, Joseph Bertram Zwischenberger, Aly El Banayosy, Federico Pappalardo, Mark S. Slaughter et al. · 2020 · ASAIO Journal
  98. CoV3D: a database of high resolution coronavirus protein structures
    Ragul Gowthaman, Johnathan D. Guest, Rui Ming Yin, Jared Adolf‐Bryfogle, William R. Schief, Brian G. Pierce · 2020 · Nucleic Acids Research
  99. Insights on SARS-CoV-2 Molecular Interactions With the Renin-Angiotensin System
    Larissa Braga Costa, Lucas Giandoni Perez, Vitória Andrade Palmeira, Thiago Macedo e Cordeiro, Victor Teatini Ribeiro, Katharina Lanza, Ana Cristina Simões e Silva · 2020 · Frontiers in Cell and Developmental Biology
  100. The Perfect Storm: COVID-19 Health Disparities in US Blacks
    Nicole Phillips, In-Woo Park, Janie R. Robinson, Harlan P. Jones · 2020 · Journal of Racial and Ethnic Health Disparities